Asrani Et Al 1

Total Page:16

File Type:pdf, Size:1020Kb

Asrani Et Al 1 Asrani et al Supplementary Figure S1: Epidermal-specific mTORC1 loss-of-function models show impaired epidermal differentiation. (A) Rheb cKO P0 epidermis fails to express spinous (Keratin 1, 10) and granular layer (loricrin, filaggrin, involucrin) differentiation markers by immunofluorescence, while the basal layer is maintained or even slightly thicker than WT (p63 and Keratin 5). Scale bar= 30 µm. (B) Rheb cKO P0 epidermal protein lysates subjected to immunoblotting confirm downregulation of K1, K10, loricrin, involucrin and transglutaminase (TGM1) 1 expression compared to WT. (C) Rptor cKO P0 epidermis shows a similar but more severe phenotype compared to Rheb cKO, with near complete loss of suprabasal keratinocyte layers in the epidermis as demonstrated by basal marker p63 immunostaining. Scale bar= 30 µm. (D) Immunoblotting of Rptor cKO vs WT P0 epidermal protein lysates confirms relative downregulation of granular markers involucrin and TGM1 with slight up-regulation of basal marker keratin 14 (K14). (E) Calcium-induced differentiation is impaired in Rheb cKO cells subjected to calcium switch assay (transfer from 0.05 mM to 2 mM calcium concentration media). While WT cells up-regulate differentiation markers (K10, loricrin, filaggrin, involucrin and TGM1) in response to exposure to 2 mM calcium for 24 hours, cKO keratinocytes show an impaired response. Basal markers (K5) are unchanged in response to calcium. (F) mTORC1 inhibition by rapamycin (200 nM) in WT keratinocytes impairs expression of spinous (K10) and granular (loricrin) differentiation markers in 2 mM calcium. Phosphorylated S6 protein (p- S6) is markedly diminished by rapamycin, confirming mTORC1 inhibition. 1 Asrani et al Supplementary Figure S2: mTORC1 loss-of-function is associated with decreased desmosomal, but not adherens, junctions. (A) Decreased expression of PKP1 (punctate dots), DSP1/2, DSG1 and DSG3 in Rptor cKO compared to WT P0 epidermis by immunofluorescence. Scale bar= 60 µm. (B) Densitometry quantification of immunoblot analysis shown in main Figure 3G (n=3; error bars represent SEM; p values indicated are by Student’s T-test). (C) Rheb cKO P0 epidermal protein lysates subjected to immunoblotting confirm lower total levels of desmosomal proteins (DSP1/2, DSG1, DSC3 and PKP1). (D) Rheb cKO P0 cultured keratinocytes show normal protein expression of adherens junction components (E-cadherin, β-catenin, α-catenin), as well as adherens junctions components (afadin) and tight junction components (ZO-1) by immunoblotting. Some actin-binding proteins such as vinculin, afadin and EPLIN show decreased levels in cKO epidermis as well. (E) Rheb cKO P0 epidermis shows normal expression of adherens junction proteins by immunofluorescence. Scale bar = 30 µm. (E) Rheb cKO keratinocytes have normal membranous levels of E-cadherin, however the distribution of staining demonstrates immature adhesion zippers rather than mature adhesion bands by immunofluorescence. Scale bar = 50 µm. 2 Asrani et al Supplementary Figure S3: mTORC1 loss-of-function is associated with increased Rho kinase activity and focal adhesion formation. (A) Increased biochemical evidence of focal adhesion formation in inducible Rptor KO keratinocytes, including increased phosphorylated paxillin (p-paxillin), focal adhesion kinase (p-FAK) and p130Cas (p-p130Cas), following calcium switch. (B) Immunofluorescence for p-paxillin and phallodin staining for f-actin demonstrates relatively rare focal adhesions in WT cells compared to Rheb cKO cells where focal adhesion and actin stress fiber formation is abundant. Scale bar = 30 µm. (C) Increased phosphorylated myosin light chain (p- MLC2) in Rheb cKO P0 epidermal lysates by immunoblotting compared to WT control. (D), (E) Lysates enriched for membrane proteins from Rheb cKO and Rptor inducible KO cultured keratinocytes demonstrate increased Rho A/B/C protein at the membrane in cells with mTORC1 loss- of-function compared to WT cells, consistent with increased Rho activity. Levels of ROCK inhibitor Rho E, by contrast, are decreased in membrane lysates from Rptor KO keratinocytes. Rho A/B/C and calreticulin in (D) were immunoblotted in parallel, contemporaneously. (F) Immunoblotting for desmosomal components (DSP1/2, DSG1, PKP1) in WT and Rheb cKO cells demonstrates rescue of total levels of desmosomal proteins with ROCK inhibition using fasudil (50 µM). ROCK activity suppression is documented by decreased p-MLC2 levels. Focal adhesion marker protein p-paxillin is also upregulated in Rheb cKO keratinocytes and is sensitive to ROCK inhibition. DSP, PKP1 and total MLC2 were immunoblotted in parallel, contemporaneously with the other markers. (G) Densitometry quantification of immunoblot experiments from Figure 6C (r=3; p-values by one-way ANOVA). (H) Densitometry quantification of immunoblot experiments from Figure 6E (r=3; p-values by one-way ANOVA). (I) . Immunoblotting of Rheb WT cells treated with ROCK1 siRNA (50nm) for ROCK1 and markers of ROCK activity, desmosomal and biochemical differentiation markers. DSP (lower panel) was immunoblotted separately from the upper panel using the same biological replicate. Error bars represent SEM throughout. 3 Asrani et al Supplementary Figure S4: ALK5 levels and TGF-β signaling are increased following mTORC1 loss-of-function and TGF-β signaling is necessary and sufficient to decrease desmosome levels in keratinocytes. (A) Immunohistochemistry for c-MYC shows more diffuse expression in Rheb cKO epidermis compared to WT where it is expressed predominantly in basal cells (scale bar=30 µm). (B) Ingenuity Pathway Analysis of the TGF- β signaling pathway from differential gene expression analysis of Rheb WT vs. cKO E18.5 epidermis. Genes within our data set whose expression showed greater than 2SD differential fold change are outlined in magenta and depicted in red (signifying up-regulation) or blue (signifying down-regulation). (C) Membranous ALK5 (TGF-β receptor I) levels are increased in Rheb cKO P0 epidermis compared to WT controls by immunohistochemistry (scale bar=30 µm). (D) ALK5 levels are increased by immunoblotting in Rptor cKO P0 epidermis compared to WT control. (E) Short-term treatment of Rptorflox/flox keratinocyte cultures treated with empty adenovirus or adenoviral-cre demonstrates increased TGF-β signaling (increased p-SMAD2 levels) and increased ROCK activation by immunoblotting (increased levels of p-MYPT1 and p-MLC2) in cells with mTORC1 inactivation with TGF-β treatment. ROCK activation is also increased in WT cells in response to TGF-β. (F) Densitometry analysis of phospho/total SMAD2, 3 expression in western blots from starved and non-starved Rptorflox/flox and inducible Rptor cKO keratinocytes demonstrates significant up-regulation in Rptor cKO keratinocytes (r=4; error bars represent SEM; p values indicated are by Student’s T-test). (G) Immunofluorescence for SMAD2, 3 demonstrates increased nuclear localization in Rptorflox/flox keratinocyte cultures treated with adenoviral-cre (scale bar=50 µm). (H) Long term (30 h) TGF-β treatment of Rptorflox/flox keratinocyte cultures treated with empty adenovirus or adenoviral-cre increases p-SMAD2, 3 levels and suppresses DSP1/2, DSG1, DSG3 and PKP3 levels by immunoblotting. (I) By immunoblotting, basal p-MLC2 and p-MYPT1 levels are decreased, and desmosome proteins (DSP1/2, DSG1, DSG3) and differentiation markers (TGM1, loricrin) are increased in Rptorflox/flox keratinocyte cultures with empty vector, treated with ALK5 inhibitor SB431542. Rheb cKO keratinocytes show uniform down-regulation of desmosomal mRNA levels under low calcium (J) conditions as well as high calcium (K) conditions. ROCK inhibition with fasudil or ALK5 inhibition with SB431542 is sufficient to rescue desmosomal mRNA levels to WT levels for most of the desmosomal transcripts (r=3; error bars represent SEM; * indicates p< 0.05 by one-way ANOVA). 4 Asrani et al Supplementary Figure S5: siRNA mediated depletion of ALK5 is sufficient to inhibit ROCK signaling and rescue desmosome levels in keratinocytes with mTORC1 loss-of-function. (A) Treatment of Inducible Rptor cKO keratinocytes with ALK5 siRNA partially suppresses p-MLC2 and ALK5 levels and rescues expression of desmosomal proteins (DSP, DSG1, DSG3, PKP3) and markers of biochemical differentiation (TGM1, loricrin) by immunoblotting. (B) Treatment of Rheb cKO keratinocytes with ALK5 siRNA partially suppresses p-MLC2 and ALK5 levels and rescues desmosomal protein expression by immunoblotting. (C) Treatment of Rheb WT keratinocytes with ALK5 siRNA partially suppresses p-MLC2 and ALK5 levels and rescues expression of desmosomal proteins (DSP, DSG1, DSG3, PKP3) and markers of biochemical differentiation (involucrin) by immunoblotting. DSP and ALK5 were immunoblotted separately using the same biological replicate. (D) Treatment of Rheb cKO keratinocytes with ALK5 siRNA increases membranous desmosomal protein levels (DSP1/2 and DSG1) and cortical f-actin (by phalloidin staining) and p-MLC2 levels by immunofluorescence (left panels) (scale bar=100 µm). Quantification of DSP and DSG1 border fluorescence (right panels) from representative images (n>28 cells, r=3; p<0.001 by Mann-Whitney test). 5 Asrani et al Supplementary Figure S6: Tentative model outlining the downstream sequalae of mTORC1 loss-of-function in the epidermis. Solid lines represent pathways substantiated in this manuscript, or by previous studies (references 41,56). Dashed lines represent potential uncharacterized consequences of mTORC1 inhibition that are the subject
Recommended publications
  • Development and Maintenance of Epidermal Stem Cells in Skin Adnexa
    International Journal of Molecular Sciences Review Development and Maintenance of Epidermal Stem Cells in Skin Adnexa Jaroslav Mokry * and Rishikaysh Pisal Medical Faculty, Charles University, 500 03 Hradec Kralove, Czech Republic; rishikaysh2007@gmail.com * Correspondence: mokry@lfhk.cuni.cz Received: 30 October 2020; Accepted: 18 December 2020; Published: 20 December 2020 Abstract: The skin surface is modified by numerous appendages. These structures arise from epithelial stem cells (SCs) through the induction of epidermal placodes as a result of local signalling interplay with mesenchymal cells based on the Wnt–(Dkk4)–Eda–Shh cascade. Slight modifications of the cascade, with the participation of antagonistic signalling, decide whether multipotent epidermal SCs develop in interfollicular epidermis, scales, hair/feather follicles, nails or skin glands. This review describes the roles of epidermal SCs in the development of skin adnexa and interfollicular epidermis, as well as their maintenance. Each skin structure arises from distinct pools of epidermal SCs that are harboured in specific but different niches that control SC behaviour. Such relationships explain differences in marker and gene expression patterns between particular SC subsets. The activity of well-compartmentalized epidermal SCs is orchestrated with that of other skin cells not only along the hair cycle but also in the course of skin regeneration following injury. This review highlights several membrane markers, cytoplasmic proteins and transcription factors associated with epidermal SCs. Keywords: stem cell; epidermal placode; skin adnexa; signalling; hair pigmentation; markers; keratins 1. Epidermal Stem Cells as Units of Development 1.1. Development of the Epidermis and Placode Formation The embryonic skin at very early stages of development is covered by a surface ectoderm that is a precursor to the epidermis and its multiple derivatives.
    [Show full text]
  • Molecular Profile of Tumor-Specific CD8+ T Cell Hypofunction in a Transplantable Murine Cancer Model
    Downloaded from http://www.jimmunol.org/ by guest on September 25, 2021 T + is online at: average * The Journal of Immunology , 34 of which you can access for free at: 2016; 197:1477-1488; Prepublished online 1 July from submission to initial decision 4 weeks from acceptance to publication 2016; doi: 10.4049/jimmunol.1600589 http://www.jimmunol.org/content/197/4/1477 Molecular Profile of Tumor-Specific CD8 Cell Hypofunction in a Transplantable Murine Cancer Model Katherine A. Waugh, Sonia M. Leach, Brandon L. Moore, Tullia C. Bruno, Jonathan D. Buhrman and Jill E. Slansky J Immunol cites 95 articles Submit online. Every submission reviewed by practicing scientists ? is published twice each month by Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts http://jimmunol.org/subscription Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html http://www.jimmunol.org/content/suppl/2016/07/01/jimmunol.160058 9.DCSupplemental This article http://www.jimmunol.org/content/197/4/1477.full#ref-list-1 Information about subscribing to The JI No Triage! Fast Publication! Rapid Reviews! 30 days* Why • • • Material References Permissions Email Alerts Subscription Supplementary The Journal of Immunology The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2016 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. This information is current as of September 25, 2021. The Journal of Immunology Molecular Profile of Tumor-Specific CD8+ T Cell Hypofunction in a Transplantable Murine Cancer Model Katherine A.
    [Show full text]
  • Associated Palmoplantar Keratoderma
    DR ABIGAIL ZIEMAN (Orcid ID : 0000-0001-8236-207X) Article type : Review Article Pathophysiology of pachyonychia congenita-associated palmoplantar keratoderma: New insight into skin epithelial homeostasis and avenues for treatment Authors: A. G. Zieman1 and P. A. Coulombe1,2 # Affiliations: 1Department of Cell and Developmental Biology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; 2Department of Dermatology, University of Michigan Medical School, Ann Arbor, MI 48109, USA #Corresponding author: Pierre A. Coulombe, PhD, 3071 Biomedical Sciences Research Building, 109 Zina Pitcher Place, Ann Arbor, MI 48109, USA. Tel: 734-615-7509. Email: coulombe@umich.edu. Funding Sources: These studies were supported by grant AR044232 issued to P.A.C. from the National Institute of Arthritis, Musculoskeletal and Skin Disease (NIAMS). A.G.Z. received support from grant T32 CA009110 from the National Cancer Institute. Author Manuscript This is the author manuscript accepted for publication and has undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between this version and the Version of Record. Please cite this article as doi: 10.1111/BJD.18033 This article is protected by copyright. All rights reserved Conflict of interest disclosures: None declared. Bulleted statements: What’s already known about this topic? Pachyonychia congenita is a rare genodermatosis caused by mutations in KRT6A, KRT6B, KRT6C, KRT16, KRT17, which are normally expressed in skin appendages and induced following injury. Individuals with PC present with multiple clinical symptoms that usually include thickened and dystrophic nails, palmoplantar keratoderma (PPK), glandular cysts, and oral leukokeratosis.
    [Show full text]
  • Propranolol-Mediated Attenuation of MMP-9 Excretion in Infants with Hemangiomas
    Supplementary Online Content Thaivalappil S, Bauman N, Saieg A, Movius E, Brown KJ, Preciado D. Propranolol-mediated attenuation of MMP-9 excretion in infants with hemangiomas. JAMA Otolaryngol Head Neck Surg. doi:10.1001/jamaoto.2013.4773 eTable. List of All of the Proteins Identified by Proteomics This supplementary material has been provided by the authors to give readers additional information about their work. © 2013 American Medical Association. All rights reserved. Downloaded From: https://jamanetwork.com/ on 10/01/2021 eTable. List of All of the Proteins Identified by Proteomics Protein Name Prop 12 mo/4 Pred 12 mo/4 Δ Prop to Pred mo mo Myeloperoxidase OS=Homo sapiens GN=MPO 26.00 143.00 ‐117.00 Lactotransferrin OS=Homo sapiens GN=LTF 114.00 205.50 ‐91.50 Matrix metalloproteinase‐9 OS=Homo sapiens GN=MMP9 5.00 36.00 ‐31.00 Neutrophil elastase OS=Homo sapiens GN=ELANE 24.00 48.00 ‐24.00 Bleomycin hydrolase OS=Homo sapiens GN=BLMH 3.00 25.00 ‐22.00 CAP7_HUMAN Azurocidin OS=Homo sapiens GN=AZU1 PE=1 SV=3 4.00 26.00 ‐22.00 S10A8_HUMAN Protein S100‐A8 OS=Homo sapiens GN=S100A8 PE=1 14.67 30.50 ‐15.83 SV=1 IL1F9_HUMAN Interleukin‐1 family member 9 OS=Homo sapiens 1.00 15.00 ‐14.00 GN=IL1F9 PE=1 SV=1 MUC5B_HUMAN Mucin‐5B OS=Homo sapiens GN=MUC5B PE=1 SV=3 2.00 14.00 ‐12.00 MUC4_HUMAN Mucin‐4 OS=Homo sapiens GN=MUC4 PE=1 SV=3 1.00 12.00 ‐11.00 HRG_HUMAN Histidine‐rich glycoprotein OS=Homo sapiens GN=HRG 1.00 12.00 ‐11.00 PE=1 SV=1 TKT_HUMAN Transketolase OS=Homo sapiens GN=TKT PE=1 SV=3 17.00 28.00 ‐11.00 CATG_HUMAN Cathepsin G OS=Homo
    [Show full text]
  • Transgenic Cyclooxygenase-2 Overexpression Sensitizes Mouse Skin for Carcinogenesis
    Transgenic cyclooxygenase-2 overexpression sensitizes mouse skin for carcinogenesis Karin Mu¨ ller-Decker*†, Gitta Neufang*, Irina Berger‡, Melanie Neumann*, Friedrich Marks*, and Gerhard Fu¨ rstenberger* *Research Program Tumor Cell Regulation, Deutsches Krebsforschungszentrum, and ‡Department of Pathology, Ruprecht-Karls-University, 69120 Heidelberg, Germany Edited by Philip Needleman, Pharmacia Corporation, St. Louis, MO, and approved July 29, 2002 (received for review May 30, 2002) Genetic and pharmacological evidence suggests that overexpres- there is a causal relationship between COX-2 overexpression sion of cyclooxygenase-2 (COX-2) is critical for epithelial carcino- and tumor development. Recently, we have shown that the genesis and provides a major target for cancer chemoprevention keratin 5 (K5) promoter-driven overexpression of COX-2 in by nonsteroidal antiinflammatory drugs. Transgenic mouse lines basal cells of interfollicular epidermis and the pilosebaceous unit with keratin 5 promoter-driven COX-2 overexpression in basal led to a preneoplastic skin phenotype in 4 of 4 high-expression epidermal cells exhibit a preneoplastic skin phenotype. As shown mouse lines (15). here, this phenotype depends on the level of COX-2 expression and To delineate COX-2 functions for carcinogenesis, we have COX-2-mediated prostaglandin accumulation. The transgenics did used the initiation–promotion model (2) for the induction of skin not develop skin tumors spontaneously but did so after a single tumors in wild-type (wt) NMRI mice and COX-2 transgenic application of an initiating dose of the carcinogen 7,12-dimethyl- mouse lines. This multistage model allows the analysis of the benz[a]anthracene (DMBA). Long-term treatment with the tumor carcinogenic process in terms of distinct stages, i.e., initiation by promoter phorbol 12-myristate 13-acetate, as required for tumor- application of a subcarcinogenic dose of a carcinogen such as igenesis in wild-type mice, was not necessary for transgenics.
    [Show full text]
  • A Cell Line P53 Mutation Type UM
    A Cell line p53 mutation Type UM-SCC 1 wt UM-SCC5 Exon 5, 157 GTC --> TTC Missense mutation by transversion (Valine --> Phenylalanine UM-SCC6 wt UM-SCC9 wt UM-SCC11A wt UM-SCC11B Exon 7, 242 TGC --> TCC Missense mutation by transversion (Cysteine --> Serine) UM-SCC22A Exon 6, 220 TAT --> TGT Missense mutation by transition (Tyrosine --> Cysteine) UM-SCC22B Exon 6, 220 TAT --> TGT Missense mutation by transition (Tyrosine --> Cysteine) UM-SCC38 Exon 5, 132 AAG --> AAT Missense mutation by transversion (Lysine --> Asparagine) UM-SCC46 Exon 8, 278 CCT --> CGT Missense mutation by transversion (Proline --> Alanine) B 1 Supplementary Methods Cell Lines and Cell Culture A panel of ten established HNSCC cell lines from the University of Michigan series (UM-SCC) was obtained from Dr. T. E. Carey at the University of Michigan, Ann Arbor, MI. The UM-SCC cell lines were derived from eight patients with SCC of the upper aerodigestive tract (supplemental Table 1). Patient age at tumor diagnosis ranged from 37 to 72 years. The cell lines selected were obtained from patients with stage I-IV tumors, distributed among oral, pharyngeal and laryngeal sites. All the patients had aggressive disease, with early recurrence and death within two years of therapy. Cell lines established from single isolates of a patient specimen are designated by a numeric designation, and where isolates from two time points or anatomical sites were obtained, the designation includes an alphabetical suffix (i.e., "A" or "B"). The cell lines were maintained in Eagle's minimal essential media supplemented with 10% fetal bovine serum and penicillin/streptomycin.
    [Show full text]
  • Seq2pathway Vignette
    seq2pathway Vignette Bin Wang, Xinan Holly Yang, Arjun Kinstlick May 19, 2021 Contents 1 Abstract 1 2 Package Installation 2 3 runseq2pathway 2 4 Two main functions 3 4.1 seq2gene . .3 4.1.1 seq2gene flowchart . .3 4.1.2 runseq2gene inputs/parameters . .5 4.1.3 runseq2gene outputs . .8 4.2 gene2pathway . 10 4.2.1 gene2pathway flowchart . 11 4.2.2 gene2pathway test inputs/parameters . 11 4.2.3 gene2pathway test outputs . 12 5 Examples 13 5.1 ChIP-seq data analysis . 13 5.1.1 Map ChIP-seq enriched peaks to genes using runseq2gene .................... 13 5.1.2 Discover enriched GO terms using gene2pathway_test with gene scores . 15 5.1.3 Discover enriched GO terms using Fisher's Exact test without gene scores . 17 5.1.4 Add description for genes . 20 5.2 RNA-seq data analysis . 20 6 R environment session 23 1 Abstract Seq2pathway is a novel computational tool to analyze functional gene-sets (including signaling pathways) using variable next-generation sequencing data[1]. Integral to this tool are the \seq2gene" and \gene2pathway" components in series that infer a quantitative pathway-level profile for each sample. The seq2gene function assigns phenotype-associated significance of genomic regions to gene-level scores, where the significance could be p-values of SNPs or point mutations, protein-binding affinity, or transcriptional expression level. The seq2gene function has the feasibility to assign non-exon regions to a range of neighboring genes besides the nearest one, thus facilitating the study of functional non-coding elements[2]. Then the gene2pathway summarizes gene-level measurements to pathway-level scores, comparing the quantity of significance for gene members within a pathway with those outside a pathway.
    [Show full text]
  • Steroid-Dependent Regulation of the Oviduct: a Cross-Species Transcriptomal Analysis
    University of Kentucky UKnowledge Theses and Dissertations--Animal and Food Sciences Animal and Food Sciences 2015 Steroid-dependent regulation of the oviduct: A cross-species transcriptomal analysis Katheryn L. Cerny University of Kentucky, katheryn.cerny@gmail.com Right click to open a feedback form in a new tab to let us know how this document benefits ou.y Recommended Citation Cerny, Katheryn L., "Steroid-dependent regulation of the oviduct: A cross-species transcriptomal analysis" (2015). Theses and Dissertations--Animal and Food Sciences. 49. https://uknowledge.uky.edu/animalsci_etds/49 This Doctoral Dissertation is brought to you for free and open access by the Animal and Food Sciences at UKnowledge. It has been accepted for inclusion in Theses and Dissertations--Animal and Food Sciences by an authorized administrator of UKnowledge. For more information, please contact UKnowledge@lsv.uky.edu. STUDENT AGREEMENT: I represent that my thesis or dissertation and abstract are my original work. Proper attribution has been given to all outside sources. I understand that I am solely responsible for obtaining any needed copyright permissions. I have obtained needed written permission statement(s) from the owner(s) of each third-party copyrighted matter to be included in my work, allowing electronic distribution (if such use is not permitted by the fair use doctrine) which will be submitted to UKnowledge as Additional File. I hereby grant to The University of Kentucky and its agents the irrevocable, non-exclusive, and royalty-free license to archive and make accessible my work in whole or in part in all forms of media, now or hereafter known.
    [Show full text]
  • Plakoglobin Is Required for Effective Intermediate Filament Anchorage to Desmosomes Devrim Acehan1, Christopher Petzold1, Iwona Gumper2, David D
    ORIGINAL ARTICLE Plakoglobin Is Required for Effective Intermediate Filament Anchorage to Desmosomes Devrim Acehan1, Christopher Petzold1, Iwona Gumper2, David D. Sabatini2, Eliane J. Mu¨ller3, Pamela Cowin2,4 and David L. Stokes1,2,5 Desmosomes are adhesive junctions that provide mechanical coupling between cells. Plakoglobin (PG) is a major component of the intracellular plaque that serves to connect transmembrane elements to the cytoskeleton. We have used electron tomography and immunolabeling to investigate the consequences of PG knockout on the molecular architecture of the intracellular plaque in cultured keratinocytes. Although knockout keratinocytes form substantial numbers of desmosome-like junctions and have a relatively normal intercellular distribution of desmosomal cadherins, their cytoplasmic plaques are sparse and anchoring of intermediate filaments is defective. In the knockout, b-catenin appears to substitute for PG in the clustering of cadherins, but is unable to recruit normal levels of plakophilin-1 and desmoplakin to the plaque. By comparing tomograms of wild type and knockout desmosomes, we have assigned particular densities to desmoplakin and described their interaction with intermediate filaments. Desmoplakin molecules are more extended in wild type than knockout desmosomes, as if intermediate filament connections produced tension within the plaque. On the basis of our observations, we propose a particular assembly sequence, beginning with cadherin clustering within the plasma membrane, followed by recruitment of plakophilin and desmoplakin to the plaque, and ending with anchoring of intermediate filaments, which represents the key to adhesive strength. Journal of Investigative Dermatology (2008) 128, 2665–2675; doi:10.1038/jid.2008.141; published online 22 May 2008 INTRODUCTION dense plaque that is further from the membrane and that Desmosomes are large macromolecular complexes that mediates the binding of intermediate filaments.
    [Show full text]
  • Patient-Based Cross-Platform Comparison of Oligonucleotide Microarray Expression Profiles
    Laboratory Investigation (2005) 85, 1024–1039 & 2005 USCAP, Inc All rights reserved 0023-6837/05 $30.00 www.laboratoryinvestigation.org Patient-based cross-platform comparison of oligonucleotide microarray expression profiles Joerg Schlingemann1,*, Negusse Habtemichael2,*, Carina Ittrich3, Grischa Toedt1, Heidi Kramer1, Markus Hambek4, Rainald Knecht4, Peter Lichter1, Roland Stauber2 and Meinhard Hahn1 1Division of Molecular Genetics, Deutsches Krebsforschungszentrum, Heidelberg, Germany; 2Chemotherapeutisches Forschungsinstitut Georg-Speyer-Haus, Frankfurt am Main, Germany; 3Central Unit Biostatistics, Deutsches Krebsforschungszentrum, Heidelberg, Germany and 4Department of Otorhinolaryngology, Universita¨tsklinik, Johann-Wolfgang-Goethe-Universita¨t Frankfurt, Frankfurt, Germany The comparison of gene expression measurements obtained with different technical approaches is of substantial interest in order to clarify whether interplatform differences may conceal biologically significant information. To address this concern, we analyzed gene expression in a set of head and neck squamous cell carcinoma patients, using both spotted oligonucleotide microarrays made from a large collection of 70-mer probes and commercial arrays produced by in situ synthesis of sets of multiple 25-mer oligonucleotides per gene. Expression measurements were compared for 4425 genes represented on both platforms, which revealed strong correlations between the corresponding data sets. Of note, a global tendency towards smaller absolute ratios was observed when
    [Show full text]
  • Hypomesus Transpacificus
    Aquatic Toxicology 105 (2011) 369–377 Contents lists available at ScienceDirect Aquatic Toxicology jou rnal homepage: www.elsevier.com/locate/aquatox Sublethal responses to ammonia exposure in the endangered delta smelt; Hypomesus transpacificus (Fam. Osmeridae) ∗ 1 2 Richard E. Connon , Linda A. Deanovic, Erika B. Fritsch, Leandro S. D’Abronzo , Inge Werner Aquatic Toxicology Laboratory, Department of Anatomy, Physiology and Cell Biology, School of Veterinary Medicine, University of California, Davis, California 95616, United States a r t i c l e i n f o a b s t r a c t Article history: The delta smelt (Hypomesus transpacificus) is an endangered pelagic fish species endemic to the Received 9 May 2011 Sacramento-San Joaquin Estuary in Northern California, which acts as an indicator of ecosystem health Received in revised form 29 June 2011 in its habitat range. Interrogative tools are required to successfully monitor effects of contaminants upon Accepted 2 July 2011 the delta smelt, and to research potential causes of population decline in this species. We used microarray technology to investigate genome-wide effects in fish exposed to ammonia; one of multiple contami- Keywords: nants arising from wastewater treatment plants and agricultural runoff. A 4-day exposure of 57-day Hypomesus transpacificus + old juveniles resulted in a total ammonium (NH4 –N) median lethal concentration (LC50) of 13 mg/L, Delta smelt ␮ Microarray and a corresponding un-ionized ammonia (NH3) LC50 of 147 g/L. Using the previously designed delta + Biomarker smelt microarray we assessed altered gene transcription in juveniles exposed to 10 mg/L NH4 –N from Ammonia this 4-day exposure.
    [Show full text]
  • Keratin 9 Point Mutation in the Pedigree of Epidermolytic Hereditary Palmoplantar Keratoderma Perturbs Keratin Intermediate Filament Network Formation
    FEBS 17004 FEBS Letters 386 (1996) 149-155 Keratin 9 point mutation in the pedigree of epidermolytic hereditary palmoplantar keratoderma perturbs keratin intermediate filament network formation Setsu Kobayashi, Toshihiro Tanaka*, Norihisa Matsuyoshi, Sadao Imamura Department of Dermatology, Graduate School of Medicine, Kyoto University, Kyoto, 606 Japan Received 12 January 1996; revised version received 4 April 1996 Abstract Keratins form an intracellular keratin filament net- point mutations in the K9 gene in EHPPK [4-8] but none work in keratinocytes. Point mutations in the epidermal keratins showed a function assay with these mutations. Here, we pro- could lead to the disruption of keratin filament formation, vide the first demonstration that the point mutation found in developing skin diseases such as epidermolytic hereditary a pedigree of EHPPK has a dominant-negative effect on the palmoplantar keratoderma (EHPPK). We found a G to A assembly of keratin intermediate filaments in the cells. transition in keratin 9 (K9) cDNA, resulting in the substitution of glutamine for arginine at 162, in all patients of a pedigree of 2. Materials and methods EHPPK. Transfection into MDCK cells and DJM-1 cells revealed that the plasmid CMX vector containing normal keratin 2.1. PCR and DNA sequence 9 cDNA showed normal keratin network formation, whereas the Genomic DNA was extracted and purified from blood or biopsy vector with a G to A point mutated keratin 9 cDNA showed specimens from the patients. The primers were designed at nucleotide disrupted keratin filaments with droplet formation in the cells. 263 282 and 664-683 based on the K9 cDNA sequence [9].
    [Show full text]